Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results
- Author
- Delphine Degré, Wim Laleman, Xavier Verhelst (UGent) , Anne Lamproye, Thomas Vanwolleghem, Thierry Gustot, Peter Starkel, Nicolas Lanthier, Peter Michielsen, Jean Delwaide, Hans Van Vlierberghe (UGent) and Frederik Nevens
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-6847916
- MLA
- Degré, Delphine, et al. “Multicenter Belgian Experience of Sofosbuvir (Medical Need Program) in Very Difficult-to-Treat HCV Patients: Safety and Efficacy Results.” ACTA GASTRO-ENTEROLOGICA BELGICA, vol. 78, no. 1, 2015.
- APA
- Degré, D., Laleman, W., Verhelst, X., Lamproye, A., Vanwolleghem, T., Gustot, T., … Nevens, F. (2015). Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results. ACTA GASTRO-ENTEROLOGICA BELGICA, 78(1).
- Chicago author-date
- Degré, Delphine, Wim Laleman, Xavier Verhelst, Anne Lamproye, Thomas Vanwolleghem, Thierry Gustot, Peter Starkel, et al. 2015. “Multicenter Belgian Experience of Sofosbuvir (Medical Need Program) in Very Difficult-to-Treat HCV Patients: Safety and Efficacy Results.” In ACTA GASTRO-ENTEROLOGICA BELGICA. Vol. 78.
- Chicago author-date (all authors)
- Degré, Delphine, Wim Laleman, Xavier Verhelst, Anne Lamproye, Thomas Vanwolleghem, Thierry Gustot, Peter Starkel, Nicolas Lanthier, Peter Michielsen, Jean Delwaide, Hans Van Vlierberghe, and Frederik Nevens. 2015. “Multicenter Belgian Experience of Sofosbuvir (Medical Need Program) in Very Difficult-to-Treat HCV Patients: Safety and Efficacy Results.” In ACTA GASTRO-ENTEROLOGICA BELGICA. Vol. 78.
- Vancouver
- 1.Degré D, Laleman W, Verhelst X, Lamproye A, Vanwolleghem T, Gustot T, et al. Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results. In: ACTA GASTRO-ENTEROLOGICA BELGICA. 2015.
- IEEE
- [1]D. Degré et al., “Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results,” in ACTA GASTRO-ENTEROLOGICA BELGICA, Brussels, Belgium, 2015, vol. 78, no. 1.
@inproceedings{6847916, author = {{Degré, Delphine and Laleman, Wim and Verhelst, Xavier and Lamproye, Anne and Vanwolleghem, Thomas and Gustot, Thierry and Starkel, Peter and Lanthier, Nicolas and Michielsen, Peter and Delwaide, Jean and Van Vlierberghe, Hans and Nevens, Frederik}}, booktitle = {{ACTA GASTRO-ENTEROLOGICA BELGICA}}, issn = {{0001-5644}}, language = {{eng}}, location = {{Brussels, Belgium}}, number = {{1}}, title = {{Multicenter Belgian experience of sofosbuvir (medical need program) in very difficult-to-treat HCV patients: safety and efficacy results}}, volume = {{78}}, year = {{2015}}, }